Details

Autor(en) / Beteiligte

• Bruder, Oliver
• Wagner, Anja
• Lombardi, Massimo
• Schwitter, Jürg
• van Rossum, Albert
• Pilz, Günter
• Nothnagel, Detlev
• Steen, Henning
• Petersen, Steffen
• Nagel, Eike
• Prasad, Sanjay
• Schumm, Julia
• Greulich, Simon
• Cagnolo, Alessandro
• Monney, Pierre
• Deluigi, Christina C
• Dill, Thorsten
• Frank, Herbert
• Sabin, Georg
• Schneider, Steffen
• Mahrholdt, Heiko

Titel

European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries

Ist Teil von

• Journal of cardiovascular magnetic resonance, 2013-01, Vol.15 (1), p.9-9, Article 9

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.